Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Performance of Susceptibility Testing for Ceftolozane/Tazobactam against Non-Carbapenemase-Producing Carbapenem-Resistant Pseudomonas aeruginosa.
Rivas L, Alcalde-Rico M, Martínez JRW, Moreno MV, Rojas P, Wozniak A, García P, Olivares-Pacheco J, Miller WR, Arias CA, Khan A, Munita JM. Rivas L, et al. Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0165721. doi: 10.1128/AAC.01657-21. Epub 2021 Nov 15. Antimicrob Agents Chemother. 2022. PMID: 34780269 Free PMC article.
Genetic characterization of clinically relevant class 1 integrons carried by multidrug resistant bacteria (MDRB) isolated from the gut microbiota of highly antibiotic treated Salmo salar.
Vásquez-Ponce F, Higuera-Llantén S, Parás-Silva J, Gamboa-Acuña N, Cortés J, Opazo-Capurro A, Ugalde JA, Alcalde-Rico M, Olivares-Pacheco J. Vásquez-Ponce F, et al. J Glob Antimicrob Resist. 2022 Jun;29:55-62. doi: 10.1016/j.jgar.2022.02.003. Epub 2022 Feb 11. J Glob Antimicrob Resist. 2022. PMID: 35158077 Free article.
Acquisition of resistance to ceftazidime-avibactam during infection treatment in Pseudomonas aeruginosa through D179Y mutation in one of two blaKPC-2 gene copies without losing carbapenem resistance.
García P, Brito B, Alcalde-Rico M, Munita JM, Martínez JRW, Olivares-Pacheco J, Quiroz V, Wozniak A. García P, et al. Among authors: alcalde rico m. Front Cell Infect Microbiol. 2022 Sep 2;12:981792. doi: 10.3389/fcimb.2022.981792. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36118031 Free PMC article.
Isolation of an Extensively Drug-Resistant Pseudomonas aeruginosa exoS+/O4 Strain Belonging to the "High-Risk" Clone ST654 and Coproducer of NDM-1 and the Novel VIM-80.
Opazo-Capurro A, Morales-León F, Jerez C, Olivares-Pacheco J, Alcalde-Rico M, González-Muñoz P, Bello-Toledo H, Cardenas-Arias A, Esposito F, Lincopán N, Illesca V, González-Rocha G. Opazo-Capurro A, et al. Among authors: alcalde rico m. Microbiol Spectr. 2022 Oct 26;10(5):e0143922. doi: 10.1128/spectrum.01439-22. Epub 2022 Oct 10. Microbiol Spectr. 2022. PMID: 36214677 Free PMC article.
Role of the multi-drug efflux systems on the baseline susceptibility to ceftazidime/avibactam and ceftolozane/tazobactam in clinical isolates of non-carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa.
Contreras-Gómez MJ, Martinez JRW, Rivas L, Riquelme-Neira R, Ugalde JA, Wozniak A, García P, Munita JM, Olivares-Pacheco J, Alcalde-Rico M. Contreras-Gómez MJ, et al. Among authors: alcalde rico m. Front Pharmacol. 2022 Oct 3;13:1007162. doi: 10.3389/fphar.2022.1007162. eCollection 2022. Front Pharmacol. 2022. PMID: 36263116 Free PMC article.
26 results